Literature DB >> 10339636

Gastric emptying in diabetes mellitus: relationship to blood-glucose control.

M F Kong1, M Horowitz.   

Abstract

The application of novel investigative techniques has established that disordered gastric motility is a frequent complication of diabetes mellitus. Thus, gastric emptying of solid or nutrient liquid meals is abnormal in 30% to 50% of randomly selected outpatients with long-standing type 1 or type 2 diabetes. Delayed gastric emptying occurs more frequently than rapid emptying. There is increasing evidence that disordered gastric motility has a major impact on the management of patients with diabetes mellitus by leading to gastrointestinal symptoms and poor glycemic control. Although both gastroparesis and upper gastrointestinal symptoms have been attributed to irreversible autonomic damage, it is now clear that acute changes in the blood-glucose concentration have a major effect on both gastrointestinal motor function and the perception of sensations arising in the gut. For example, there is an inverse relationship between the rate of gastric emptying and the blood-glucose concentration, so that gastric emptying is slower during hyperglycemia and accelerated during hypoglycemia. This article reviews some issues in the etiology, diagnosis, and management of problems associated with gastric emptying in elderly persons with diabetes mellitus.

Entities:  

Mesh:

Year:  1999        PMID: 10339636

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  20 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

2.  Metoclopramide in the treatment of diabetic gastroparesis.

Authors:  Allen Lee; Braden Kuo
Journal:  Expert Rev Endocrinol Metab       Date:  2010

Review 3.  Effect of age-related changes in gastric physiology on tolerability of medications for older people.

Authors:  Julia L Newton
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 4.  Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.

Authors:  Ake Norberg; A Wayne Jones; Robert G Hahn; Johan L Gabrielsson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  Gender and estradiol as major factors in the expression and dimerization of nNOSα in rats with experimental diabetic gastroparesis.

Authors:  M Showkat Ali; Iliana Tiscareno-Grejada; Silviu Locovei; Rebecca Smiley; Todd Collins; Jerzy Sarosiek; Richard McCallum
Journal:  Dig Dis Sci       Date:  2012-06-10       Impact factor: 3.199

6.  Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.

Authors:  N J Talley; M Verlinden; D J Geenen; R B Hogan; D Riff; R W McCallum; R J Mack
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

Review 7.  Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and treatment.

Authors:  Nicolas Intagliata; Kenneth L Koch
Journal:  Curr Gastroenterol Rep       Date:  2007-08

Review 8.  Cellular pathogenesis of diabetic gastroenteropathy.

Authors:  T Ordög; Y Hayashi; S J Gibbons
Journal:  Minerva Gastroenterol Dietol       Date:  2009-09

Review 9.  Diabetic gastroparesis: functional/morphologic background, diagnosis, and treatment options.

Authors:  Viktor J Horváth; Ferenc Izbéki; Csaba Lengyel; Péter Kempler; Tamás Várkonyi
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 10.  Current concepts in diabetic gastroparesis.

Authors:  D Scott Smith; Christopher D Ferris
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.